{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:03:50Z","timestamp":1784667830063,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.compbiomed.2026.111680","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:56:57Z","timestamp":1775897817000},"page":"111680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Generative deep learning\u2013driven de novo design of targeted MAP4K6 inhibitors"],"prefix":"10.1016","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0967-3079","authenticated-orcid":false,"given":"Shakeel Ahmad","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2026.111680_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004686","article-title":"The role of misshapen NCK-related kinase (MINK), a novel Ste20 family kinase, in the IRES-mediated protein translation of human enterovirus 71","volume":"11","author":"Leong","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.compbiomed.2026.111680_bib2","doi-asserted-by":"crossref","first-page":"13811","DOI":"10.3390\/cimb46120826","article-title":"Clinical potential of Misshapen\/NIKs-related kinase (MINK) 1\u2014A many-sided element of cell physiology and pathology","volume":"46","author":"Kot","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111680_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.compbiomed.2026.111680_bib4","unstructured":"Expression of MINK1 in cancer - summary - the human protein atlas, (n.d.). https:\/\/www.proteinatlas.org\/ENSG00000141503-MINK1\/cancer (accessed December 17, 2024)."},{"key":"10.1016\/j.compbiomed.2026.111680_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1207496","article-title":"Mechanism of sorafenib resistance associated with ferroptosis in HCC","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111680_bib6","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.3390\/cancers16234059","article-title":"Current treatment methods in hepatocellular carcinoma","volume":"16","author":"Krupa","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.compbiomed.2026.111680_bib7","volume":"44","author":"Ntellas","year":"2024"},{"key":"10.1016\/j.compbiomed.2026.111680_bib8","doi-asserted-by":"crossref","DOI":"10.2217\/hep-2018-0002","article-title":"Hepatocellular carcinoma treatment: hurdles, advances and prospects","volume":"5","author":"Kumari","year":"2018","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.compbiomed.2026.111680_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2217\/fon.14.291","article-title":"Sorafenib off-target effects predict outcomes in patients treated for hepatocellular carcinoma","volume":"11","author":"Di Costanzo","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.compbiomed.2026.111680_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ctrv.2019.05.004","article-title":"Management of adverse events associated with tyrosine kinase inhibitors: improving outcomes for patients with hepatocellular carcinoma","volume":"77","author":"Rimassa","year":"2019","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.compbiomed.2026.111680_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jgh.15727","article-title":"Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma","volume":"37","author":"Kim","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2026.111680_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102434","article-title":"Mechanisms of sorafenib resistance in hepatocellular carcinoma","volume":"48","author":"Liang","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.compbiomed.2026.111680_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104069","article-title":"New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma","volume":"29","author":"Fan","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.compbiomed.2026.111680_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bioorg.2014.05.008","article-title":"Applications of structure-based design to antibacterial drug discovery","volume":"55","author":"Cain","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-03567-2","article-title":"High-throughput screening of small molecule inhibitors of the streptococcus quorum-sensing signal pathway","volume":"7","author":"Ishii","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2026.111680_bib16","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1021\/acs.jcim.0c01496","article-title":"Generative deep learning for targeted compound design","volume":"61","author":"Sousa","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2026.111680_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/acscentsci.7b00512","article-title":"Generating focused molecule libraries for drug discovery with recurrent neural networks","volume":"4","author":"Segler","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.compbiomed.2026.111680_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","article-title":"Automatic chemical design using a data-driven continuous representation of molecules","volume":"4","author":"G\u00f3mez-Bombarelli","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.compbiomed.2026.111680_bib19","doi-asserted-by":"crossref","first-page":"13664","DOI":"10.1039\/D1SC04444C","article-title":"Structure-based de novo drug design using 3D deep generative models","volume":"12","author":"Li","year":"2021","journal-title":"Chem. Sci."},{"issue":"10","key":"10.1016\/j.compbiomed.2026.111680_bib20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s42256-021-00403-1","article-title":"Multi-constraint molecular generation based on conditional transformer, knowledge distillation and reinforcement learning","volume":"3","author":"Wang","year":"2021","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.compbiomed.2026.111680_bib21","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.compbiomed.2026.111680_bib22","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.drudis.2021.05.019","article-title":"De novo molecular design and generative models","volume":"26","author":"Meyers","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.compbiomed.2026.111680_bib23","doi-asserted-by":"crossref","first-page":"14011","DOI":"10.1021\/acs.jmedchem.1c00927","article-title":"Generative Models for De Novo Drug Design","volume":"64","author":"Tong","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib24","series-title":"ICLR 2022 - 10th International Conference on Learning Representations","article-title":"Data-efficient graph grammar learning for molecular generation","author":"Guo","year":"2022"},{"key":"10.1016\/j.compbiomed.2026.111680_bib25","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s11030-024-10942-5","article-title":"Application progress of deep generative models in de novo drug design","volume":"28","author":"Liu","year":"2024","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111680_bib26","first-page":"1","article-title":"Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2026.111680_bib27","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1021\/acs.jcim.8b00839","article-title":"GuacaMol: benchmarking Models for de Novo Molecular Design","volume":"59","author":"Brown","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2026.111680_bib28","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2026.111680_bib29","unstructured":"Misshapen like kinase 1 | MSN subfamily | IUPHAR\/BPS guide to PHARMACOLOGY, (n.d.). https:\/\/www.guidetopharmacology.org\/GRAC\/ObjectDisplayForward?objectId=2103 (accessed November 18, 2024)."},{"key":"10.1016\/j.compbiomed.2026.111680_bib30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.21105\/joss.00861","article-title":"UMAP: uniform manifold approximation and projection","volume":"3","author":"McInnes","year":"2018","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.compbiomed.2026.111680_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.compbiomed.2026.111680_bib32","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.compbiomed.2026.111680_bib35","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib36","unstructured":"Try TMAP, (n.d.). https:\/\/try-tmap.gdb.tools\/(accessed August 26, 2024)."},{"key":"10.1016\/j.compbiomed.2026.111680_bib37","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.4155\/fmc-2016-0093","article-title":"AutoQSAR: an automated machine learning tool for best-practice quantitative structure-activity relationship modeling","volume":"8","author":"Dixon","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib38","series-title":"Schr\u00f6dinger Release 2023-1","year":"2023"},{"key":"10.1016\/j.compbiomed.2026.111680_bib39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.compbiomed.2026.111680_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107711","article-title":"Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules","volume":"101","author":"Marondedze","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.compbiomed.2026.111680_bib41","unstructured":"misshapen-like kinase 1 isoform 4 [homo sapiens] - protein - NCBI, (n.d.). https:\/\/www.ncbi.nlm.nih.gov\/protein\/NP_001020108.1?report=fasta (accessed November 24, 2024)."},{"key":"10.1016\/j.compbiomed.2026.111680_bib42","unstructured":"SWISS-MODEL - SIB Swiss Institute of Bioinformatics | Expasy, (n.d.). https:\/\/www.expasy.org\/resources\/swiss-model (accessed November 24, 2024)."},{"key":"10.1016\/j.compbiomed.2026.111680_bib43","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkab225","article-title":"Expasy, the Swiss bioinformatics resource portal, as designed by its users","volume":"49","author":"Duvaud","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2026.111680_bib44","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1021\/jm500155b","article-title":"Discovery of selective 4-amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization","volume":"57","author":"Crawford","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib46","series-title":"Schr\u00f6dinger Release 2023-1, Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2023; Impact, Schr\u00f6dinger, LLC","year":"2023"},{"key":"10.1016\/j.compbiomed.2026.111680_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/bib\/bbae032","article-title":"Integrating network pharmacology and in silico analysis deciphers withaferin-a\u2019s anti-breast cancer potential via hedgehog pathway and target network interplay","volume":"25","author":"Srinivasan","year":"2024","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2026.111680_bib48","author":"Chow"},{"key":"10.1016\/j.compbiomed.2026.111680_bib49","article-title":"Exploring the mechanism of curcumin in the treatment of colon cancer based on network pharmacology and molecular docking","volume":"14","author":"He","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111680_bib50","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/metabo13050658","article-title":"Computational insights into natural antischistosomal metabolites as SmHDAC8 inhibitors: molecular docking, ADMET profiling, and molecular dynamics simulation","volume":"13","author":"Alzain","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.compbiomed.2026.111680_bib51","series-title":"Schr\u00f6dinger Release 2023-1, Glide","year":"2023"},{"key":"10.1016\/j.compbiomed.2026.111680_bib52","unstructured":"V. 3. 0 S.LLC. The Pymol Molecular Graphics System, Pymol, (n.d.)."},{"key":"10.1016\/j.compbiomed.2026.111680_bib53","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1039\/D2NJ01397E","article-title":"A study of drug candidates derived from pleconaril for inhibiting coxsackievirus B3 (Cvb3) by ADMET, molecular docking, molecular dynamics and retrosynthesis","volume":"46","author":"Moukhliss","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib54","first-page":"1","article-title":"Investigating the molecular interactions of quinoline derivatives for antibacterial activity against bacillus subtilis: computational biology and in vitro study interpretations","author":"Setlur","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.compbiomed.2026.111680_bib55","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the opls force field","volume":"6","author":"Shivakumar","year":"2010","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.compbiomed.2026.111680_bib56","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1063\/1.463940","article-title":"Nos\u00e9\u2013Hoover chains: the canonical ensemble via continuous dynamics","volume":"97","author":"Martyna","year":"1992","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2026.111680_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107322","article-title":"Geo-measures: a PyMOL plugin for protein structure ensembles analysis","volume":"87","author":"Kagami","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.compbiomed.2026.111680_bib59","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1162\/neco.1997.9.8.1735","article-title":"Long short-term memory","volume":"9","author":"Hochreiter","year":"1997","journal-title":"Neural Comput."},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111680_bib60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s42256-020-0160-y","article-title":"Generative molecular design in low data regimes","volume":"2","author":"Moret","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.compbiomed.2026.111680_bib61","author":"Makhzani"},{"key":"10.1016\/j.compbiomed.2026.111680_bib62","series-title":"2nd International Conference on Learning Representations, ICLR 2014 - Conference Track Proceedings","article-title":"Auto-encoding variational bayes","author":"Kingma","year":"2013"},{"key":"10.1016\/j.compbiomed.2026.111680_bib63","author":"Guimaraes"},{"key":"10.1016\/j.compbiomed.2026.111680_bib64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymeth.2023.02.001","article-title":"DNMG: deep molecular generative model by fusion of 3D information for de novo drug design","volume":"211","author":"Song","year":"2023","journal-title":"Methods"},{"key":"10.1016\/j.compbiomed.2026.111680_bib65","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1021\/acs.jctc.2c01171","article-title":"Strategy toward kinase-selective drug discovery","volume":"19","author":"Zhang","year":"2023","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.compbiomed.2026.111680_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cimb46120826","article-title":"Clinical potential of Misshapen\/nIKs-related kinase (MINK) 1\u2014A many-sided element of cell physiology and pathology","volume":"46","author":"Kot","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.compbiomed.2026.111680_bib67","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.5c00641","article-title":"Generative Deep Learning for de Novo Drug Design\u2500A Chemical Space Odyssey","author":"\u00d6z\u00e7elik","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2026.111680_bib68","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1021\/acs.jcim.4c01314","article-title":"An open-source implementation of the scaffold identification and naming system (SCINS) and example applications","volume":"64","author":"Petrov","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2026.111680_bib69","unstructured":"Bemis-murcko clustering | chemaxon docs, (n.d.). https:\/\/docs.chemaxon.com\/display\/docs\/jklustor_bemis-murcko-clustering.md (accessed September 29, 2025)."},{"key":"10.1016\/j.compbiomed.2026.111680_bib70","series-title":"Proceedings - 2024 IEEE 20th International Conference on e-Science, e-Science 2024","article-title":"Generative AI for research data processing: lessons learnt from three use cases","author":"Mitra","year":"2025"},{"key":"10.1016\/j.compbiomed.2026.111680_bib71","first-page":"1","article-title":"Accelerating discovery of bioactive ligands with pharmacophore-informed generative models","volume":"16","author":"Xie","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111680_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44386-025-00017-2","article-title":"Recent advances in molecular representation methods and their applications in scaffold hopping","volume":"2","author":"Wang","year":"2025","journal-title":"Npj Drug Discovery"},{"key":"10.1016\/j.compbiomed.2026.111680_bib73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-1-62703-023-6_16","article-title":"Predicting biological activities through QSAR analysis and docking-based scoring","volume":"914","author":"Vilar","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.compbiomed.2026.111680_bib74","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/j.ejmech.2010.06.024","article-title":"Ligand and structure based pharmacophore modeling to facilitate novel histone deacetylase 8 inhibitor design","volume":"45","author":"Thangapandian","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib75","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/bs.apha.2025.01.013","article-title":"Real-world application of molecular docking in drug discovery","volume":"103","author":"Dutta","year":"2025","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111680_bib76","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/17460441.2021.1942836","article-title":"What is the current value of MM\/PBSA and MM\/GBSA methods in drug discovery?","volume":"16","author":"Tuccinardi","year":"2021","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.compbiomed.2026.111680_bib77","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1021\/acs.jcim.9b00843","article-title":"Exploring ligand stability in protein crystal structures using binding pose metadynamics","volume":"60","author":"Fusani","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2026.111680_bib78","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111680_bib79","article-title":"From QSAR to dynamics: a data-driven design of drug-like lactam-based HDAC inhibitors for diffuse large B-cell lymphoma","volume":"1","author":"Isah","year":"2025","journal-title":"Silico Research in Biomedicine"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482526002441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482526002441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:42:36Z","timestamp":1784666556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482526002441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":78,"alternative-id":["S0010482526002441"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111680","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generative deep learning\u2013driven de novo design of targeted MAP4K6 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111680"}}